Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-DC-20-002 from the NIH Guide for Grants and Contracts. The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities to medical students and resident-investigators in otolaryngology and foster their ability to transition to individual career developmen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 22, 2020 Category: Research Source Type: funding

Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-20-084)
Notice NOT-EB-20-019 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2020 Category: Research Source Type: funding

Notice of Change to Key Dates for RFA-OH-20-001 Miner Safety and Health Training Program - Western United States (U60)
Notice NOT-OH-20-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Update for RFA-OH-21-003 "Extension of the World Trade Center Health Registry (U50)"
Notice NOT-OH-21-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Update for RFA-OH-21-004 "Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)"
Notice NOT-OH-21-002 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Update for PAR-20-280 "Cooperative Research Agreements Related to the World Trade Center Health Program (U01)"
Notice NOT-OH-21-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Request for Information: Response to Proposed NIH Rehabilitation Research Plan Objectives
Notice NOT-HD-20-033 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Clarification of the Role of the Intramural Investigator in PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
Notice NOT-HD-20-029 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Pre-Application Webinar for RFA-TR-20-030, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
Notice NOT-TR-20-037 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Request for Information: Ambitious Collaborative Goals for Bioelectronic Medicine
Notice NOT-RM-20-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Drug Development Collaboratory (UG3/UH3 Clinical Trial Required)
Funding Opportunity PAR-20-301 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch (TDB) and extramural researchers, for therapeutic development of small molecules, biologics, or gene therapies. The UG3 phase will provide support for late stage pre-clinical work and clinical trial planning that is conducted at applicant institutions. The goal of any collaboration with TDB is to enable an IND application by the end of the UG3 phase. ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Notice of Change to RFA-AG-21-016 "Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)"
Notice NOT-AG-20-050 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-043 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites multiple-PD/PI applications for collaborative research projects that will comprise a new incubator program within the Cancer Intervention and Surveillance Modeling Network (CISNET). The overarching goal of this FOA is to expand comparative simulation modeling approaches developed by CISNET to cancer sites beyond the sites which have been previously funded under CISNET (breast, colorectal, prostate, lung, esophageal, and cervical). This "incubat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 18, 2020 Category: Research Source Type: funding

NIAID Research Education Program (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-289 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIAID R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs of NIAID mission areas. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2020 Category: Research Source Type: funding

BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-20-556 from the NIH Guide for Grants and Contracts. This FOA is related to the transformative project, "A Cell Type-Specific Armamentarium for Understanding Brain Function and Dysfunction," described in the "The BRAIN Initiative 2.0: From Cells to Circuits, Toward Cures" report of the Advisory Committee to the NIH Director BRAIN Initiative Working Group 2.0. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2020 Category: Research Source Type: funding

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-NS-21-010 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-20-010: The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials. Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent. The scope of t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 16, 2020 Category: Research Source Type: funding

Reminder: NIH Policy on Use of Hypertext in NIH Grant Applications
Notice NOT-OD-20-174 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 16, 2020 Category: Research Source Type: funding

Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
Notice NOT-HL-20-814 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-TR-20-031 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
Funding Opportunity RFA-TR-20-032 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support basket clinical trials of drugs targeting shared molecular etiologies in more than one rare disease. To facilitate clinical trial start up, and leverage existing datasets, preference will be given to applications focusing on diseases that are under study by the Rare Disease Clinical Research Network (RDCRN), and that involve collaborations with RDCRN clinical investigators. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)
Funding Opportunity RFA-CA-20-051 from the NIH Guide for Grants and Contracts. The purpose of this RFA is to solicit applications to develop, adapt, and test individual-, community- or multilevel interventions to address modifiable risk factors for cancer in rural populations. Proposals should focus on primary prevention and assess and address one or more of the social and behavioral risk factors that contribute to cancer disparities in rural populations. Proposals should also assess and address myriad social determinants of health, cultural factors, and health care and technology access barriers that may contribute to ru...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Application Form Issue with PAR-18-799 NIOSH Mentored Research Scientist Development Award (K01)
Notice NOT-OH-20-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Application Form Issue with PAR-18-797 NIOSH Small Research Grant Program (R03)
Notice NOT-OH-20-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Application Form Issue with PAR-18-812 Occupational Safety and Health Research (R01)
Notice NOT-OH-20-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Change to Key Dates for RFA-NS-18-019 "BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)"
Notice NOT-NS-20-108 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Application Form Issue with PAR-18-798 Occupational Safety and Health Research (R21)
Notice NOT-OH-20-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-304 from the NIH Guide for Grants and Contracts. NLM wishes to accelerate the availability of and access to secure, complete data sets and computational models that can serve as the basis of transformative biomedical discoveries by improving the speed and scope of the curation processes. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Extension of the Expiration Date for PAR-18-336 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trial Required)
Notice NOT-CA-20-099 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Expiration of PA-17-247 - Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
Notice NOT-HS-20-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Change: Expansion of Research Scope of RFA-OD-19-029 The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)"
Notice NOT-OD-20-168 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding

Notice of Change to Key Dates for RFA-NS-18-020 "BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"
Notice NOT-NS-20-109 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-21-015 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applicants to participate in a new NHLBI phenomics program, HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets (hereafter referred to as HeartShare). The goal of this program is to conduct large-scale analysis of phenotypic data, images, and omics from patients with heart failure with preserved ejection fraction (HFpEF) in order to characterize mechanisms of disease and identify therapeutic targets. This FOA solicits applications for Clinical Centers (...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-21-016 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applicants to participate in a new NHLBI phenomics program, HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets (hereafter referred to as HeartShare). The goal of this program is to conduct large-scale analysis of phenotypic data, images, and omics from patients with heart failure with preserved ejection fraction (HFpEF) in order to characterize mechanisms of disease and identify therapeutic targets. This FOA solicits applications for a Data Translation...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-291 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-290 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Small Research Grant (R03) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R03 grant mechanism supports different types ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2020 Category: Research Source Type: funding

Policy for Charging Personal Protective Equipment to NIH Grants and Cooperative Agreements as Direct Costs
Notice NOT-OD-20-164 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding

Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
Notice NOT-HD-20-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding

Notice of Limited Availability of Research Non-human Primates
Notice NOT-OD-20-173 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Funding Opportunity PAR-20-300 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric ?precision therapeutics. (Source: NIH Fundi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Funding Opportunity PAR-20-299 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics. (Source: NIH Fundin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding

Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp)
Notice NOT-NS-20-038 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2020 Category: Research Source Type: funding

Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Scientific Data Research Center (U24 Clinical Trial Required)
Funding Opportunity RFA-DK-20-507 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limite...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Clinical Centers (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-20-506 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limite...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Notice of Extension of the Expiration Date for PAR-18-364 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)"
Notice NOT-CA-20-101 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Notice of Extension of the Expiration Date for PAR-18-337 "NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08, No Independent Clinical Trials)"
Notice NOT-CA-20-100 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design
Notice NOT-AI-20-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

NOTICE of eligibility change for PAR-18-901: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)
Notice NOT-TW-20-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Reminder: NIH Natural Disaster Policy Hurricane Laura
Notice NOT-OD-20-172 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Updated Information on the Research Projects Component for PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
Notice NOT-OH-20-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding

Notice of Extension of the Expiration Date for PAR-18-366 "NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials)"
Notice NOT-CA-20-103 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2020 Category: Research Source Type: funding